Today, the EVP, COO & Pres-CooperVision of Cooper Co (NYSE: COO), Daniel Mcbride, sold shares of COO for $504.8K.
In addition to Daniel Mcbride, 2 other COO executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Cooper Co’s latest earnings report for the quarter ending April 30, the company posted quarterly revenue of $631 million and quarterly net profit of $60.9 million. In comparison, last year the company earned revenue of $533 million and had a net profit of $105 million. COO’s market cap is $11.56B and the company has a P/E ratio of 90.74. Currently, Cooper Co has an average volume of 445K.
Based on 5 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $266.40, reflecting a -11.3% downside.
The insider sentiment on Cooper Co has been negative according to 43 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Cooper Cos, Inc. operates as a medical device company. It operates through the following business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers.
